GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » Interest Expense

Star Combo Pharma (ASX:S66) Interest Expense : A$-0.19 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Star Combo Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Star Combo Pharma's interest expense for the six months ended in Dec. 2024 was A$ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.19 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Star Combo Pharma's Operating Income for the six months ended in Dec. 2024 was A$ 0.02 Mil. Star Combo Pharma's Interest Expense for the six months ended in Dec. 2024 was A$ -0.01 Mil. Star Combo Pharma's Interest Coverage for the quarter that ended in Dec. 2024 was 1.45. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Star Combo Pharma Interest Expense Historical Data

The historical data trend for Star Combo Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Combo Pharma Interest Expense Chart

Star Combo Pharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Interest Expense
Get a 7-Day Free Trial -0.39 -0.24 -0.17 -0.19 -0.20

Star Combo Pharma Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.17 -0.02 -0.18 -0.01

Star Combo Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Combo Pharma  (ASX:S66) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Star Combo Pharma's Interest Expense for the six months ended in Dec. 2024 was A$-0.01 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$0.02 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$3.79 Mil.

Star Combo Pharma's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*0.016/-0.011
=1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Star Combo Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » Interest Expense
Comparable Companies
ASX:PTL ASX:ZNO ASX:MCP ASX:SKN PG XPAR:OR LSE:ULVR CL BOM:500696 KMB LSE:RKT KVUE XTER:HEN3 XTER:BEI CHD EL TSE:4452 CLX OSTO:ESSITY B TSE:8113
Traded in Other Exchanges
N/A
Address
171 - 177 Woodpark Road, Smithfield, Sydney, NSW, AUS, 2164
Website
https://www.starcombo.com.au
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

Star Combo Pharma Headlines

No Headlines